HEPATORENAL SYNDROME WITH ACUTE RENAL FAILURE IN PATIENTS WITH CHRONIC LIVER DISEASE: MODERN ASPECTS OF CLINICAL PRESENTATION AND INTENSIVE CARE

Introduction. Acute renal failure is considered a functional, progressive, oliguric, but reversible kidney disease that occurs due to severe liver disease with hepatic insufficiency. In the development of the syndrome, the leading role is played by the “classical hypothesis of peripheral vasodilatio...

Full description

Saved in:
Bibliographic Details
Main Authors: R. R. Nagimullin, F. A. Shipulin, A. Zh. Bayalieva
Format: Article
Language:English
Published: Bashkir State Medical University 2018-08-01
Series:Креативная хирургия и онкология
Subjects:
Online Access:https://www.surgonco.ru/jour/article/view/304
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849394446860288000
author R. R. Nagimullin
F. A. Shipulin
A. Zh. Bayalieva
author_facet R. R. Nagimullin
F. A. Shipulin
A. Zh. Bayalieva
author_sort R. R. Nagimullin
collection DOAJ
description Introduction. Acute renal failure is considered a functional, progressive, oliguric, but reversible kidney disease that occurs due to severe liver disease with hepatic insufficiency. In the development of the syndrome, the leading role is played by the “classical hypothesis of peripheral vasodilation”. Important differentiation in verification of diagnosis is primarily with pseudo hepatorenal syndrome. In the type I (of hepatorenal syndrome) mortality in the first 10 days without an adequate management in intensive care unit is extremely high. The chronic, type II, is a slow process, but requires adequate therapy for up to six months. In general, all clinical manifestations of hepatorenal syndrome are combined into three groups: cardiac insufficiency, systemic vasodilation, and vasoconstriction of renal vessels. The goals of the therapy include restoration of blood flow through the vessels, management of inflammatory processes, prevention of further hepatic tissue destruction, and stabilization of arterial blood pressure in kidney vessels. The core in medical management is adequate albumin infusion and minimal crystalloid support of blood volume, vasopressors, adequate antidote and antibacterial therapy. Additional methods include extracorporeal albumin dialysis to bridge patient to liver transplantation. The orthotopic liver transplantation is the established surgical treatment, as well as transjugular intrahepatic portosystemic shunt (TIPS) or peritoneovenous shunt. Survival rate of patients with hepatorenal syndrome type I on terlipressin in patients with hypoalbuminemia correction is close to 60–75%; survival of with hepatorenal syndrome type II is more favorable in most cases.Methods. The literature review examines diagnostics possibilities of hepatorenal syndrome, importance of timely relevant differential diagnoses and adequate intensive care management.Conclusion. The differential diagnosis between hepatorenal syndrome and pseudo hepatorenal syndrome remains a challenge in routine diagnostic examinations. Intensive care management of such patients requires immediate treatment, which may not be always the most appropriate option. The refore new strategies are needed to improve management of this medical condition.
format Article
id doaj-art-ebb1c1b8a5c14ae192622fc58196dbbc
institution Kabale University
issn 2076-3093
2307-0501
language English
publishDate 2018-08-01
publisher Bashkir State Medical University
record_format Article
series Креативная хирургия и онкология
spelling doaj-art-ebb1c1b8a5c14ae192622fc58196dbbc2025-08-20T03:39:58ZengBashkir State Medical UniversityКреативная хирургия и онкология2076-30932307-05012018-08-0181768310.24060/2076-3093-2018-8-1-76-83266HEPATORENAL SYNDROME WITH ACUTE RENAL FAILURE IN PATIENTS WITH CHRONIC LIVER DISEASE: MODERN ASPECTS OF CLINICAL PRESENTATION AND INTENSIVE CARER. R. Nagimullin0F. A. Shipulin1A. Zh. Bayalieva2Kazan State Medical University; City Clinical Hospital №7Kazan State Medical University; City Clinical Hospital №7Kazan State Medical UniversityIntroduction. Acute renal failure is considered a functional, progressive, oliguric, but reversible kidney disease that occurs due to severe liver disease with hepatic insufficiency. In the development of the syndrome, the leading role is played by the “classical hypothesis of peripheral vasodilation”. Important differentiation in verification of diagnosis is primarily with pseudo hepatorenal syndrome. In the type I (of hepatorenal syndrome) mortality in the first 10 days without an adequate management in intensive care unit is extremely high. The chronic, type II, is a slow process, but requires adequate therapy for up to six months. In general, all clinical manifestations of hepatorenal syndrome are combined into three groups: cardiac insufficiency, systemic vasodilation, and vasoconstriction of renal vessels. The goals of the therapy include restoration of blood flow through the vessels, management of inflammatory processes, prevention of further hepatic tissue destruction, and stabilization of arterial blood pressure in kidney vessels. The core in medical management is adequate albumin infusion and minimal crystalloid support of blood volume, vasopressors, adequate antidote and antibacterial therapy. Additional methods include extracorporeal albumin dialysis to bridge patient to liver transplantation. The orthotopic liver transplantation is the established surgical treatment, as well as transjugular intrahepatic portosystemic shunt (TIPS) or peritoneovenous shunt. Survival rate of patients with hepatorenal syndrome type I on terlipressin in patients with hypoalbuminemia correction is close to 60–75%; survival of with hepatorenal syndrome type II is more favorable in most cases.Methods. The literature review examines diagnostics possibilities of hepatorenal syndrome, importance of timely relevant differential diagnoses and adequate intensive care management.Conclusion. The differential diagnosis between hepatorenal syndrome and pseudo hepatorenal syndrome remains a challenge in routine diagnostic examinations. Intensive care management of such patients requires immediate treatment, which may not be always the most appropriate option. The refore new strategies are needed to improve management of this medical condition.https://www.surgonco.ru/jour/article/view/304pseudohepatorenal syndromesystemic vasodilationvasoconstrictorsextracorporeal albumin dialysisorthotopic liver transplantationshunt
spellingShingle R. R. Nagimullin
F. A. Shipulin
A. Zh. Bayalieva
HEPATORENAL SYNDROME WITH ACUTE RENAL FAILURE IN PATIENTS WITH CHRONIC LIVER DISEASE: MODERN ASPECTS OF CLINICAL PRESENTATION AND INTENSIVE CARE
Креативная хирургия и онкология
pseudohepatorenal syndrome
systemic vasodilation
vasoconstrictors
extracorporeal albumin dialysis
orthotopic liver transplantation
shunt
title HEPATORENAL SYNDROME WITH ACUTE RENAL FAILURE IN PATIENTS WITH CHRONIC LIVER DISEASE: MODERN ASPECTS OF CLINICAL PRESENTATION AND INTENSIVE CARE
title_full HEPATORENAL SYNDROME WITH ACUTE RENAL FAILURE IN PATIENTS WITH CHRONIC LIVER DISEASE: MODERN ASPECTS OF CLINICAL PRESENTATION AND INTENSIVE CARE
title_fullStr HEPATORENAL SYNDROME WITH ACUTE RENAL FAILURE IN PATIENTS WITH CHRONIC LIVER DISEASE: MODERN ASPECTS OF CLINICAL PRESENTATION AND INTENSIVE CARE
title_full_unstemmed HEPATORENAL SYNDROME WITH ACUTE RENAL FAILURE IN PATIENTS WITH CHRONIC LIVER DISEASE: MODERN ASPECTS OF CLINICAL PRESENTATION AND INTENSIVE CARE
title_short HEPATORENAL SYNDROME WITH ACUTE RENAL FAILURE IN PATIENTS WITH CHRONIC LIVER DISEASE: MODERN ASPECTS OF CLINICAL PRESENTATION AND INTENSIVE CARE
title_sort hepatorenal syndrome with acute renal failure in patients with chronic liver disease modern aspects of clinical presentation and intensive care
topic pseudohepatorenal syndrome
systemic vasodilation
vasoconstrictors
extracorporeal albumin dialysis
orthotopic liver transplantation
shunt
url https://www.surgonco.ru/jour/article/view/304
work_keys_str_mv AT rrnagimullin hepatorenalsyndromewithacuterenalfailureinpatientswithchronicliverdiseasemodernaspectsofclinicalpresentationandintensivecare
AT fashipulin hepatorenalsyndromewithacuterenalfailureinpatientswithchronicliverdiseasemodernaspectsofclinicalpresentationandintensivecare
AT azhbayalieva hepatorenalsyndromewithacuterenalfailureinpatientswithchronicliverdiseasemodernaspectsofclinicalpresentationandintensivecare